Cancer Gene Therapy - Table of Contents alert Volume 20 Issue 11

TABLE OF CONTENTS Volume 20, Issue 11 (November 2013) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Collections TCGA pan-cancer analysis The Cancer Genome Atlas Pan-cancer initiative examines the similarities and differences among the genomic and cellular alterations found in the first dozen tumor types to be profiled by TCGA. This first look across cancer offers new tools in genomics and bioinformatics and the prospect of repurposing targeted therapies directed by the molecular pathology of the tumors in addition to their clinical classification. Access the Collection and accompanying Podcast, FREE at: www.nature.com/tcga  Produced with support from  Illumina  Review Top Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application A Tanemura, E Kiyohara, I Katayama and Y Kaneda Cancer Gene Ther 2013 20: 599-605; advance online publication, October 25, 2013; 10.1038/cgt.2013.61 Abstract | Full Text Original Articles Top Grp78 as a therapeutic target for refractory head–neck cancer with CD24−CD44+ stemness phenotype C-C Chiu, L-Y Lee, Y-C Li, Y-J Chen, Y-C Lu, Y-L Li, H-M Wang, J T Chang and A-J Cheng Cancer Gene Ther 2013 20: 606-615; advance online publication, November 8, 2013; 10.1038/cgt.2013.64 Abstract | Full Text Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV D N Yarde, S Naik, R A Nace, K-W Peng, M J Federspiel and S J Russell Cancer Gene Ther 2013 20: 616-621; advance online publication, November 1, 2013; 10.1038/cgt.2013.63 Abstract | Full Text Downregulation of G3BPs inhibits the growth, migration and invasion of human lung carcinoma H1299 cells by suppressing the Src/FAK-associated signaling pathway H Zhang, S-h Zhang, H-w He, C-x Zhang, D-k Yu and R-g Shao Cancer Gene Ther 2013 20: 622-629; advance online publication, October 25, 2013; 10.1038/cgt.2013.62 Abstract | Full Text Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy M Opyrchal, C Allen, P Msaouel, I Iankov and E Galanis Cancer Gene Ther 2013 20: 630-637; advance online publication, October 25, 2013; 10.1038/cgt.2013.58 Abstract | Full Text Oral contrast enhances the resolution of in-life NIS reporter gene imaging L Suksanpaisan, L Pham, S McIvor, S J Russell and K-W Peng Cancer Gene Ther 2013 20: 638-641; advance online publication, September 13, 2013; 10.1038/cgt.2013.57 Abstract | Full Text Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer A Rojas-Martínez, A G Manzanera, S W Sukin, J Esteban-María, J F González-Guerrero, L Gomez-Guerra, R Garza-Guajardo, J P Flores-Gutiérrez, G Elizondo Riojas, I Delgado-Enciso, R Ortiz-López, L K Aguilar, E B Butler, H A Barrera-Saldaña and E Aguilar-Cordova Cancer Gene Ther 2013 20: 642-649; advance online publication, September 20, 2013; 10.1038/cgt.2013.56 Abstract | Full Text Advertisement Read the most requested articles from Gene Therapy in 2013.  Immunotherapy with gene-modified T cells: limiting side effects provides new challenges  Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART Visit www.nature.com/gt to sign up for the monthly e-Alert or to submit your research.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.